ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
45 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
2.5K
|
852K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
68 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
2.5K
|
852K
|
68
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
40 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
2.5K
|
852K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
41 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
2.5K
|
852K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
55 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
2.5K
|
852K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
45 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
2.5K
|
852K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
41 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
307
|
97K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
46 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
307
|
97K
|
46
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
6 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
307
|
97K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
135 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
307
|
97K
|
135
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
126 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
97K
|
126
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
14 |
13/08/24 |
13/08/24 |
General
|
12K
|
4.2M
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
9 |
13/08/24 |
13/08/24 |
General
|
12K
|
4.2M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
38 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
307
|
97K
|
38
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
44 |
13/08/24 |
13/08/24 |
General
|
12K
|
4.2M
|
44
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
51 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
307
|
97K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Davisite
|
307 |
97K |
58 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
307
|
97K
|
58
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
22K |
8.1M |
67 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
22K
|
8.1M
|
67
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
22K |
8.1M |
76 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
22K
|
8.1M
|
76
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
22K |
8.1M |
27 |
11/08/24 |
11/08/24 |
ASX - By Stock
|
22K
|
8.1M
|
27
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
41 |
11/08/24 |
11/08/24 |
General
|
12K
|
4.2M
|
41
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
28 |
11/08/24 |
11/08/24 |
General
|
12K
|
4.2M
|
28
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
42 |
08/08/24 |
08/08/24 |
General
|
12K
|
4.2M
|
42
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
13 |
08/08/24 |
08/08/24 |
General
|
12K
|
4.2M
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
114 |
08/08/24 |
08/08/24 |
General
|
12K
|
4.2M
|
114
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
18 |
07/08/24 |
07/08/24 |
General
|
12K
|
4.2M
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
12K |
4.2M |
61 |
07/08/24 |
07/08/24 |
General
|
12K
|
4.2M
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Davisite
|
924 |
287K |
55 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
924
|
287K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Davisite
|
2 |
1.9K |
87 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
2
|
1.9K
|
87
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Davisite
|
924 |
287K |
38 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
924
|
287K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
Davisite
|
221 |
83K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
221
|
83K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
33 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
34K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
31 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
35 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
42 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
42
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Davisite
|
6 |
2.4K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
6
|
2.4K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
11 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
37 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Davisite
|
81 |
24K |
12 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
81
|
24K
|
12
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review and Appendix 4C
|
|
Davisite
|
8 |
3.6K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
8
|
3.6K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Davisite
|
81 |
24K |
71 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
81
|
24K
|
71
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Davisite
|
81 |
24K |
18 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
81
|
24K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Davisite
|
81 |
24K |
58 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
81
|
24K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Davisite
|
132 |
34K |
30 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
132
|
34K
|
30
|
|
ASX - By Stock
|
SIS |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Davisite
|
5 |
2.9K |
2 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5
|
2.9K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
79 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
2.5K
|
852K
|
79
|
|
ASX - By Stock
|
IDA |
Re:
Ann: US$90 Million Settlement With Tanzania
|
|
Davisite
|
98 |
37K |
8 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
98
|
37K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Davisite
|
924 |
287K |
13 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
924
|
287K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
2.5K |
852K |
23 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
2.5K
|
852K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Davisite
|
924 |
287K |
30 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
924
|
287K
|
30
|
|